Health Care
-
October FDA Approvals Beyond Cancer: Hives, Schizophrenia, Eye Disease, Hepatitis B and Crohn Disease
From allergy to ophthalmology, new October treatments bring first-in-class options and at-home therapies for chronic conditions and rare diseases.
-
How Texas’ $6B CPRIT Outpaces NIH in Speeding Cancer Breakthroughs
The state’s aggressive funding model recruits top researchers and accelerates treatments—while federal grants face slower bureaucratic hurdles.
-
Cancer Researchers Face Funding Gaps and Scientific Hurdles as Personal Stories Drive Public Support
Despite rising prevention knowledge and fundraising success, scientists cite funding instability and complex tumor biology as key barriers to progress in cancer…
-
GammaTile Trial Shows 1.3% Recurrence at One Year Versus 15.4% After Standard Radiation
HOUSTON, October 2 — GT Medical Technologies announced on September 29, 2026, that the results of the randomized, multicenter ROADS trial (NCT04365374)…
-
Harvard Cancer Researchers Retract 2019 Paper Over Duplicated Images
BOSTON, July 17 — A research paper whose corresponding author is a prominent Boston oncologist has been retracted, raising questions in the…
-
Opioid Crisis Moved From Painkillers to Heroin to Fentanyl in Waves, Study Finds
WASHINGTON, July 16 — The opioid epidemic, described by doctors and researchers as “one of the most devastating public health catastrophes of…
-
Pioneering pharmacologist honored for breast cancer breakthrough
WASHINGTON, July 15 — V. Craig Jordan, the British-American pharmacologist whose work turned tamoxifen into a cornerstone of hormone-positive breast cancer therapy,…
-
New Alzheimer’s Drug Lecanemab Slows Cognitive Decline in Trial
WASHINGTON, July 14 — For the millions of American families watching a loved one slowly lose their memories, the arrival of lecanemab…
-
Alberta Cancer Foundation Commits $35 Million to Cancer Clinical Trials
EDMONTON, July 7 — Wendy Beauchesne has spent the last six years at the helm of the Alberta Cancer Foundation, and on…
-
Owerko Centre Among Sites Sharing Alberta Cancer Foundation’s $35M Trials Fund
CALGARY, July 7 — A major investment announced yesterday is set to transform how quickly families across Alberta, and potentially beyond, can…
-
Germany’s Lack of Heat Protection Rules Endangers Nursing Homes
A national policy gap is now impossible to ignore in Germany. The country has no federal heat protection regulations requiring cooling systems…
-
Multilevel training model to speed child cancer diagnosis in Ethiopia
ADDIS ABABA — A new training and mentorship model is showing early promise in accelerating the diagnosis of childhood cancer in Northwest…
-
Virginia Cancer Specialists: 21 Doctors in Top Docs Hall of Fame
FAIRFAX, June 17 — Virginia Cancer Specialists announced that 21 of its physicians have been named to the Washingtonian “Top Doctors” Hall…
-
Roche Launches 7-Minute Lung Cancer Injection in India to Replace Hours-Long IV Infusions
For lung cancer patients in India, the treatment chair has been a fixed point — hours of intravenous drip, hospital waits, repeated…
-
MAHA Push Is Changing How Americans Snack, NIQ Data Shows
WASHINGTON, D.C. — The slogan “Make America Healthy Again” is not new. Its roots stretch back decades through the public-health work of…
-
Federal Registry Tracks Firefighter Cancer to Find Prevention Methods Nationwide
For decades, firefighters have faced a grim reality: the very substances they encounter while battling blazes can trigger cancer years later. Benzene,…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Dynasty Trusts Preserve Wealth for a Century Using GST Exemptions
-
How Major Medical Centers Partner With Tech Firms for Next-Gen Proton Therapy
-
FDA Denies Approval for Summit Therapeutics’ Ivonescimab in Lung Cancer
-
How will the next era of precision thoracic oncology change treatment choices for lung‑cancer patients?
-
FDA Approval Moves Astellas’ Padcev Into Curative Bladder Cancer Setting
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
Navigating 7% Mortgage Rates: Strategies for Buying a Home Now
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992

















